Quantcast

Genomics Market worth $19.0 Billion by 2018

January 27, 2014

DALLAS, January 27, 2014 /PRNewswire/ –

New analysis from MarketsandMarkets “Genomics Market by Products – [Instruments (NGS
platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction &
Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) -
Global Forecast to 2018″, finds that the Global Genomics Market earned revenues of $11.11
billion in 2013 and estimates this market to reach over $19.0 billion by 2018.

Browse 49 market data tables and 52 figures spread through 248 pages and in-depth TOC
on “Genomics Market”

http://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html

Early buyers will receive 10% customization on this report.

The report segments the Global Genomics Market by products (instrument, consumables,
and services), by technology (Nucleic acid extraction & purification, PCR, DNA sequencing,
and DNA microarray), by application (diagnostics, personalized medicine, academic
research, agriculture & animal health, and academic research), and by geography (North
America, Europe, APAC, and RoW). Technological advancements (Nanopore sequencing,
customized microarray, and d-PCR), increasing capital investment by public and private
capitalists in genetic researches, as well as innovations in bioinformatics tools for
advanced application in drug discovery and academic research are considered the key
drivers for the global Genomics Market.

“The future of Genomics lies in the personalized medicine industry. Government
initiatives and considerable investments are expected to drive genetic research on
personalized medicines that utilize base pairs of the human genome sequence”, notes
MarketsandMarkets Research Analyst.

As of now, the application of personalized medicine is primarily focused on drug
discovery for oncology, vaccine production, as well as infectious disease-therapeutic
areas. The usage and application areas for genomic research in personalized medicine are
expected to increase significantly in coming years.

Over the last decade, Tier I and Tier II companies were found to be dominant in the
instruments and consumables product segments of the Genomics Market. Moreover, increasing
market consolidation through consecutive restructuring activities by leading players has
proved to be a challenge for new entrants. “Market penetration in the Genomics services
sub-segment would be a suitable strategy for start-ups. Increasing dependency of small and
medium scale research institutes on outsourced services is expected to drive the market
significantly,” concludes Antan. “Partnering with Tier I and Tier II manufacturers reduces
the initial capital investment, and allows small scale service providers to leverage
established brand names for market penetration.” Leading market players in this market
include Roche Diagnostic (Switzerland), Life Technologies, Corp. (U.S.), QIAGEN
(Netherlands), Illumina, Inc. (U.S.), and Bio-Rad Laboratories, Inc. (U.S.).

The Global Genomics Market study is part of the Biotechnology subscription title,
which also includes research in the following markets: Next Generation Sequencing (NGS)
Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche),
Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics,
Personalized Medicine)] – Global Forecast to 2017, and Proteomics Market (Protein
Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface
Plasmon Resonance, X-ray Crystallography) – Instruments, Reagents & Services – Trends &
Global Forecasts to 2017.All research reports from MarketsandMarkets provide detailed
tables and forecasts following extensive interviews with market participants.

Browse related reports

Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life
Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq),
(Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] – Global Forecast to
2017

http://www.marketsandmarkets.com/Market-Reports/next-generation-sequencing-ngs-technologies-market-546.html

Proteomics Market (Protein Microarray, Mass Spectrometry, NMR Spectroscopy,
Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) -
Instruments, Reagents & Services – Trends & Global Forecasts to 2017

http://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.html

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S.
We publish strategically analyzed market research reports and serve as a business
intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and
custom research services. MarketsandMarkets covers thirteen industry verticals; including
advanced materials, automotives and transportation, banking and financial services,
biotechnology, healthcare information technology, chemicals, consumer goods,
telecommunications and IT, energy and power, food and beverages, industrial automation,
medical devices, pharmaceuticals, agriculture industry, semiconductor and electronics,
aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository.

        Contact:
        Mr. Rohan
        North - Dominion Plaza
        17304 Preston Road
        Suite 800, Dallas, TX 75252
        Tel: +1-888-600-6441
        Email: sales@marketsandmarkets.com
        Visit MarketsandMarkets Blog @

http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology

        Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

SOURCE MarketsandMarkets


Source: PR Newswire



comments powered by Disqus